의료 사기 탐지 시장 : 시장 예측(2026-2032년)

The Healthcare Fraud Detection Market is projected to grow by USD 9.81 billion at a CAGR of 17.41% by 2032.

Healthcare fraud detection has become a strategic priority as payers, providers, public health agencies, and regulators confront increasingly complex schemes across claims, billing, prescriptions, telehealth, identity, and procurement workflows. Fraud, waste, and abuse can include upcoding, unbundling, phantom billing, kickbacks, medical identity theft, duplicate claims, unnecessary services, and false documentation. Verified enforcement guidance from public health oversight bodies consistently identifies healthcare fraud as a persistent risk to patient safety, program integrity, and public expenditure accountability. Because healthcare transactions involve high volumes of sensitive clinical, financial, and demographic data, effective fraud detection now depends on integrating claims analytics, clinical review, provider behavior monitoring, identity verification, and compliance controls. The shift from retrospective audits to near-real-time fraud analytics is improving the ability to identify suspicious patterns earlier, prioritize high-risk cases, reduce false positives, and protect patient trust. Search interest and investment are increasingly aligned around keywords such as healthcare fraud detection, healthcare fraud analytics, claims fraud detection, AI in healthcare fraud, payment integrity, fraud waste and abuse prevention, and medical identity fraud detection, reflecting a broader move toward data-driven governance in healthcare systems.

Transformative Shifts in the Healthcare Fraud Detection Landscape

The healthcare fraud detection landscape is being reshaped by digital claims submission, interoperable health records, e-prescribing, remote care, and value-based reimbursement models. These changes create both stronger audit trails and new fraud vulnerabilities. Telehealth expansion has increased convenience and access, but it has also required stronger verification of patient identity, provider credentials, service necessity, location of service, and documentation quality. Value-based care has shifted attention from isolated claim lines to longitudinal patient outcomes, risk adjustment accuracy, referral patterns, care coordination integrity, and coding compliance. At the same time, regulators and payers are emphasizing prevention over pay-and-chase recovery, encouraging earlier detection through pre-payment edits, anomaly detection, provider risk scoring, and continuous monitoring. Cyber-enabled fraud, synthetic identities, compromised credentials, and ransomware-linked data exposure are also pushing healthcare organizations to align fraud detection with cybersecurity, data privacy, and identity access management. The result is a more integrated payment integrity ecosystem where operational, clinical, financial, and compliance teams work from shared risk signals rather than disconnected audit queues.

Cumulative Impact of Artificial Intelligence on Fraud Detection

Artificial intelligence is significantly changing healthcare fraud detection by enabling faster pattern recognition across structured and unstructured data. Machine learning models can identify abnormal billing frequency, unusual service combinations, outlier provider behavior, duplicate or conflicting claims, excessive utilization, and suspicious patient-provider relationships. Natural language processing supports review of clinical notes, prior authorization records, discharge summaries, and medical necessity documentation, while graph analytics helps uncover collusive networks involving providers, beneficiaries, pharmacies, laboratories, durable medical equipment suppliers, and intermediaries. Generative AI is also emerging as a productivity tool for summarizing case files, accelerating investigator workflows, drafting investigation narratives, and improving fraud investigation documentation; however, it introduces governance requirements around explainability, hallucination control, model validation, privacy, human oversight, and auditability. The most effective use of AI in healthcare fraud detection combines automated risk scoring with human clinical and investigative judgment. Organizations are increasingly adopting responsible AI practices, including bias monitoring, data lineage controls, model performance testing, reproducibility checks, role-based access controls, and compliance oversight, to ensure that fraud analytics supports fair, transparent, and defensible decisions.

Key Regional Insights Across Global Healthcare Fraud Detection

Asia-Pacific is experiencing rapid digitization of healthcare systems, expanding insurance coverage, and growing use of electronic health records, which together increase the need for stronger claims fraud analytics and identity verification. Countries with large public health schemes and fast-growing private insurance participation are prioritizing payment integrity, especially in high-volume outpatient, pharmacy, diagnostic, telemedicine, and hospital billing environments. Europe benefits from broad public healthcare coverage, national insurance controls, cross-border collaboration, and data protection frameworks, but must balance healthcare fraud analytics with strict privacy, consent, proportionality, and ethical data use requirements. North America remains a highly advanced region for healthcare fraud detection due to mature claims infrastructure, strong regulatory scrutiny, extensive payer analytics, and established fraud, waste, and abuse enforcement practices. In the United States and Canada, healthcare organizations increasingly rely on predictive analytics, provider profiling, audit trails, pre-payment review, and medical identity controls to strengthen compliance and reduce improper payments. Latin America is advancing through digital health modernization, public insurance reforms, electronic invoicing, and anti-corruption initiatives, with fraud detection gaining importance in procurement, claims validation, prescription oversight, and provider billing controls. Africa's healthcare fraud detection landscape is developing alongside health financing reforms, mobile health adoption, digital identity initiatives, and donor-funded program oversight, with particular focus on beneficiary authentication, medicine supply chain integrity, procurement transparency, and public health expenditure accountability. The Middle East is investing in digital health platforms, insurance modernization, centralized health information exchanges, and smart government initiatives, creating demand for automated claims adjudication, coding compliance, pre-authorization integrity, and fraud prevention across public and private healthcare systems.

Key Group Insights for Healthcare Fraud Detection Adoption

NATO member countries overlap significantly with advanced digital health, public-sector resilience, and cybersecurity policy environments, reinforcing the convergence of healthcare fraud detection, cyber risk management, medical identity protection, and secure health data exchange. G7 countries generally operate more mature healthcare data and enforcement infrastructures, enabling broader adoption of advanced analytics, AI-based fraud scoring, pre-payment controls, and integrated payment integrity programs. BRICS economies face diverse but substantial fraud detection needs due to large populations, mixed public-private healthcare financing, rapid insurance digitization, and expanding national health platforms; common priorities include claims validation, public program integrity, procurement monitoring, beneficiary authentication, and detection of provider billing anomalies. The European Union's approach is shaped by public healthcare systems, cross-border health policy coordination, anti-fraud cooperation, and strict data protection rules, requiring fraud analytics solutions that are privacy-preserving, explainable, auditable, and aligned with governance standards. ASEAN countries are strengthening healthcare fraud detection as universal health coverage initiatives, private insurance growth, and digital health adoption increase claims volumes and transaction complexity. Regional priorities include eligibility verification, provider credentialing, pharmacy claims review, telehealth validation, and controls for high-frequency outpatient services. GCC countries are advancing rapidly through national digital health strategies, mandatory or expanding health insurance frameworks, centralized health data platforms, and e-claims infrastructure, making claims fraud detection, coding compliance, pre-authorization integrity, and provider behavior monitoring key operational priorities.

Key Country Insights in Healthcare Fraud Detection

China is using healthcare digitization, insurance fund supervision, national health data initiatives, and large-scale claims review mechanisms to detect improper billing, false claims, inflated services, and misuse of public insurance funds. The United States is one of the most enforcement-intensive healthcare fraud detection environments, with strong focus on Medicare, Medicaid, private insurance claims, opioid-related fraud, laboratory billing, durable medical equipment schemes, telehealth billing integrity, and medical identity theft. Japan's aging population, universal coverage structure, and advanced health data systems make billing accuracy, long-term care fraud detection, prescription controls, and provider compliance important priorities. India's expanding public health protection schemes, private hospital networks, digital health identity infrastructure, and insurance platforms create significant need for claims fraud analytics, hospital empanelment monitoring, pre-authorization review, and beneficiary authentication. Germany's statutory health insurance framework, extensive provider networks, e-prescription progress, and digital health expansion support greater use of billing analytics and compliance monitoring. The United Kingdom focuses on public system integrity, prescription fraud, procurement oversight, dental and optical claims controls, and counter-fraud governance supported by centralized data practices. Australia emphasizes Medicare compliance, provider education, prescription monitoring, digital health safeguards, and analytics-led identification of irregular billing. France applies strong public health administration and insurance controls to address inappropriate billing, prescription irregularities, supplier risks, and provider behavior anomalies. South Korea's advanced digital healthcare infrastructure and national insurance system support sophisticated review of claims patterns, medical utilization, provider anomalies, and unnecessary care indicators. Italy and Spain are strengthening healthcare fraud prevention through public procurement transparency, prescription monitoring, regional health system audits, and digital billing controls. Canada emphasizes public payer stewardship, provincial health system oversight, provider billing review, and data-driven anomaly detection to safeguard healthcare expenditure and service access. Russia's fraud detection priorities include public insurance oversight, regional health expenditure monitoring, procurement controls, and digital claims review. Brazil's large public health system and private insurance segment create demand for analytics that can identify irregular claims, procurement risks, medicine supply concerns, and service utilization anomalies. Mexico is advancing fraud detection through digital health and insurance modernization, with attention to public procurement, provider billing controls, claims validation, and identity verification.

Actionable Recommendations for Healthcare Fraud Detection Leaders

Industry leaders should move fraud detection upstream by integrating pre-payment analytics, identity verification, provider credential monitoring, clinical documentation review, and coding validation into core claims workflows. A strong strategy begins with clean, interoperable data across claims, electronic health records, pharmacy systems, prior authorization platforms, provider directories, and identity management systems. Organizations should deploy layered analytics that combine rules-based edits, machine learning, graph analytics, natural language processing, and expert clinical review to improve detection accuracy and reduce false positives. Governance is equally important: leaders should establish model validation processes, explainability standards, privacy controls, investigator feedback loops, exception handling protocols, and measurable case outcomes. Collaboration with regulators, law enforcement, payers, providers, cybersecurity teams, and public health agencies can improve intelligence sharing while preserving patient confidentiality. Healthcare organizations should also train billing teams and providers on compliance risks, since prevention through education is often more efficient than post-payment recovery. Finally, fraud detection programs should be continuously updated to reflect emerging risks in telehealth, behavioral health, pharmacy benefits, laboratory testing, durable medical equipment, risk adjustment, long-term care, procurement, and cyber-enabled medical identity fraud.

Research Methodology for Evidence-Based Healthcare Fraud Insights

This executive summary is structured around evidence-based secondary research, regulatory guidance, public health fraud enforcement priorities, healthcare payment integrity practices, digital health policy developments, and documented use cases for analytics and artificial intelligence in fraud detection. The methodology emphasizes triangulation of publicly available and verifiable information from government agencies, health authorities, law enforcement publications, standards bodies, academic literature, audit reports, and compliance frameworks. Insights were evaluated for relevance to claims fraud detection, fraud waste and abuse prevention, provider billing integrity, medical identity protection, AI governance, procurement oversight, and regional healthcare system dynamics. The analysis excludes market sizing, market share, revenue estimates, and forecasts, focusing instead on qualitative intelligence, operational trends, regional adoption patterns, and strategic implications for healthcare stakeholders. Country and regional insights were synthesized by examining healthcare financing models, digital health maturity, regulatory intensity, insurance structures, enforcement priorities, data protection requirements, and known fraud risk categories.

Conclusion: Building Resilient Healthcare Fraud Detection Programs

Healthcare fraud detection is moving from reactive investigation toward proactive, intelligence-led prevention. As healthcare systems digitize and transaction volumes rise, fraud schemes are becoming more sophisticated, making advanced analytics, artificial intelligence, graph-based investigation, clinical validation, and identity controls essential components of payment integrity. Regional, group, and country-level adoption varies according to healthcare financing, regulatory maturity, data infrastructure, enforcement intensity, and digital health readiness, but the strategic direction is consistent: organizations need earlier detection, stronger governance, and more coordinated oversight. The next phase of healthcare fraud detection will depend on responsible AI, interoperable data, privacy-preserving analytics, secure identity management, and close collaboration across payers, providers, regulators, and public agencies. Leaders that combine technology with clinical expertise, compliance discipline, cybersecurity awareness, and continuous risk monitoring will be better positioned to reduce fraud, protect patients, and strengthen trust in healthcare systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Healthcare Fraud Detection Market, by Component

• 7.1. Introduction
• 7.2. Software
  • 7.2.1. Fraud Analytics Software
  • 7.2.2. Predictive Modeling Software
  • 7.2.3. Case Management Software
  • 7.2.4. Reporting & Dashboard Software
• 7.3. Services
  • 7.3.1. Consulting Services
  • 7.3.2. Implementation Services
  • 7.3.3. Managed Services
  • 7.3.4. Training Services

8. Healthcare Fraud Detection Market, by Deployment

• 8.1. Introduction
• 8.2. Cloud
• 8.3. On Premise

9. Healthcare Fraud Detection Market, by Fraud Type

• 9.1. Introduction
• 9.2. Billing Fraud
• 9.3. Identity Theft
• 9.4. Insurance Fraud
• 9.5. Pharmaceutical Fraud

10. Healthcare Fraud Detection Market, by Application

• 10.1. Introduction
• 10.2. Billing
• 10.3. Claims Management
• 10.4. Enrollment Fraud
• 10.5. Prescription Fraud

11. Healthcare Fraud Detection Market, by End User

• 11.1. Introduction
• 11.2. Hospitals
  • 11.2.1. Private Hospitals
  • 11.2.2. Public Hospitals
• 11.3. Payers
  • 11.3.1. Government Payers
  • 11.3.2. Private Payers
• 11.4. Pharmacies
  • 11.4.1. Online
  • 11.4.2. Retail

12. Healthcare Fraud Detection Market, by Organization Size

• 12.1. Introduction
• 12.2. Large Enterprises
• 12.3. Medium-Sized Organizations
• 12.4. Small Organizations

13. Healthcare Fraud Detection Market, by Region

• 13.1. Asia-Pacific
• 13.2. Europe
• 13.3. North America
• 13.4. Latin America
• 13.5. Africa
• 13.6. Middle East

14. Healthcare Fraud Detection Market, by Group

• 14.1. NATO
• 14.2. G7
• 14.3. BRICS
• 14.4. European Union
• 14.5. ASEAN
• 14.6. GCC

15. Healthcare Fraud Detection Market, by Country

• 15.1. China
• 15.2. United States
• 15.3. Japan
• 15.4. India
• 15.5. Germany
• 15.6. United Kingdom
• 15.7. Australia
• 15.8. France
• 15.9. South Korea
• 15.10. Italy
• 15.11. Canada
• 15.12. Russia
• 15.13. Brazil
• 15.14. Mexico
• 15.15. Spain

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Booz Allen Hamilton Holding Corporation
• 17.2. CGI Inc.
• 17.3. Cognizant Technology Solutions Corporation
• 17.4. Conduent Incorporated
• 17.5. Cotiviti, Inc.
• 17.6. Fair Isaac Corporation
• 17.7. Gainwell Technologies LLC
• 17.8. HCL Technologies Limited
• 17.9. HMS Holdings Corp.
• 17.10. IBM Corporation
• 17.11. Infosys Limited
• 17.12. Inovalon Holdings, Inc.
• 17.13. IQVIA Holdings Inc.
• 17.14. LexisNexis Risk Solutions Inc.
• 17.15. McKesson Corporation
• 17.16. Milliman, Inc.
• 17.17. Optum, Inc.
• 17.18. Oracle Corporation
• 17.19. SAS Institute Inc.
• 17.20. The SSI Group, LLC
• 17.21. Thomson Reuters
• 17.22. UnitedHealth Group Incorporated
• 17.23. Verisk Analytics, Inc.
• 17.24. Wipro Limited
• 17.25. Zelis Healthcare, LLC